PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.67%
Revenue growth above 1.5x FSLR's 2.22%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
-177.61%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-80.71%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
33.93%
Positive operating income growth while FSLR is negative. John Neff might view this as a competitive edge in operations.
-76.09%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-75.00%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-75.00%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.08%
Share count expansion well above FSLR's 0.04%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.08%
Slight or no buyback while FSLR is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
83.73%
OCF growth above 1.5x FSLR's 17.62%. David Dodd would confirm a clear edge in underlying cash generation.
56.28%
FCF growth above 1.5x FSLR's 32.05%. David Dodd would verify if the firm’s strategic investments yield superior returns.
-35.00%
Negative 10Y revenue/share CAGR while FSLR stands at 21.90%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-38.39%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
17.44%
Positive 3Y CAGR while FSLR is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
-132.84%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-168.88%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
91.47%
Positive 3Y OCF/share CAGR while FSLR is negative. John Neff might see a big short-term edge in operational efficiency.
-405.40%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-709.40%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-19.28%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
-111.66%
Negative equity/share CAGR over 10 years while FSLR stands at 163.45%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-116.09%
Negative 5Y equity/share growth while FSLR is at 9.82%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-113.86%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-13.76%
Firm’s AR is declining while FSLR shows 1.01%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-19.52%
Inventory is declining while FSLR stands at 28.01%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-24.74%
Negative asset growth while FSLR invests at 0.38%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-393.59%
We have a declining book value while FSLR shows 0.76%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-54.80%
We’re deleveraging while FSLR stands at 0.15%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-0.80%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-29.30%
We cut SG&A while FSLR invests at 53.07%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.